Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients

The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2009 by Temple University.
Recruitment status was  Recruiting
Sponsor:
Collaborator:
Wyeth is now a wholly owned subsidiary of Pfizer
Information provided by:
Temple University
ClinicalTrials.gov Identifier:
NCT00999258
First received: October 20, 2009
Last updated: NA
Last verified: October 2009
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: June 2011
  Estimated Primary Completion Date: June 2011 (Final data collection date for primary outcome measure)